Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 533543 | NSE Symbol : BROOKS | ISIN : INE650L01011 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
26-Dec-2024	26-Dec-2024	Change in Other Executives	Appointment Ms Krutika Mohan Rane as Company Secretary and Compliance Officer wef from 26 Dec 2024
07-Dec-2024	11-Dec-2024	Preferential Issue	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2024 inter alia to consider and approve fund raising through preferential issue of equity shares Board of Directors approved as follow - 1) FUND RAISE OF UPTO RS. 75.00 CRORES THROUGH ISSUE OF EQUITY SHARES ON PREFERENTIAL BASIS 2) FORMATION OF FUND RAISING COMMITTEE (As Per Bse Announcement Dated on 11.12.2024)
06-Nov-2024	09-Nov-2024	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting under Regulation 30 & Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement dated on 09.11.2024)
06-Aug-2024	14-Aug-2024	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended on June 30 2024 Outcome of Board Meeting (As per BSE Announcement Dated on 14/08/2024)
07-Aug-2024	07-Aug-2024	Change in Directors	Appointment of Additional Independent Director(s).
12-May-2024	18-May-2024	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended 31st March 2024. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2024. Financial Results for Quarter and Financial Year ended March 31,2024 (As Per BSE Announcement Dated on 18.05.2024)
24-Jan-2024	31-Jan-2024	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results. Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (As per BSE Announcement Dated on 31/01/2024)
16-Jan-2024	24-Jan-2024	Right Issue	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve fund raising through Rights issue. The Board Meeting to be held on 24/01/2024 Stands Cancelled. Further to our letter dated January 16, 2024, intimating the exchange about the Board Meeting to be held on January 24, 2024, we further wish to inform that the agenda items are amended as below: (As per BSE Announcement Dated on 17/01/2024) Issue Of Warrants & Preferential Issue of shares & Rights Issue (As per BSE Bulletin dated on 17/01/2024) Outcome of Board Meeting (As Per BSE Announcement dated on 24.01.2024)
31-Oct-2023	09-Nov-2023	Half Yearly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the Half year and quarter ended September 30 2023. Outcome of Board Meeting Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September,2023 along with Review Report issued by M/s J C Ranpura & Co. Chartered Accountant for the quarter /half year ended 30th September,2023 Financial Results for September 30, 2023 (As Per BSE Announcement Dated on 09/11/2023)
23-Aug-2023	23-Aug-2023	Change in Directors	Appointment of Mr. Bhushan Singh Rana as an Additional Director (Executive) of the Company.
02-Aug-2023	10-Aug-2023	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Intimation of Board Meeting to be held on 10th August 2023 for approving unaudited financials for the 1st quarter ended 30th June2023. Outcome of Board Meeting for approval of unaudited quarterly results for June 30,2023 (As Per BSE Announcement dated on 10.08.2023)
03-Jul-2023	18-Jul-2023	Right Issue	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2023 inter alia to consider and approve 1. the issue price and issue size for the proposed Right Issue. 2. the Exchange Ratio / Rights entitlement ratio for the proposed Right Issue. 3. To fix Record Date to ascertain the eligible shareholders for the proposed Right Issue. 4. To determine issue opening date issue closing date and last date for market renunciation. 5. Taking on record and adopting the Letter of Offer (LOF) along with the Abridged Letter of Offer (ALOF) Rights Entitlement Letter (REL) Composite Application Form (CAF). 6. Any other matter incidental and connected to Right Issue. Board Meeting Intimation for Rescheduling Of Meeting To July 18, 2023 BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2023 ,inter alia, to consider and approve matters related to rights issue. (As Per BSE Bulletin dated on 10.07.2023) Outcome of the meeting of the Board of Directors held on July 18, 2023 for determination of Rights Issue matters. (As per BSE Announcement Dated on 18/07/2023)
20-May-2023	29-May-2023	Accounts	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended March 31 2023. Board Meeting Outcome For Submission of Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31, 2023. (As Per BSE Announcement dated on 29.05.2023)
03-Feb-2023	14-Feb-2023	Quarterly Results	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2022. Outcome of Board Meeting for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022 Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022 (As per BSE Announcement Dated on 14/02/2023)
19-Jan-2023	25-Jan-2023	Right Issue	BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 inter alia to consider and approve Right Issue of Equity Shares and Postal Ballot Notice Outcome of Board Meeting for approval of Rights Issue and Postal Ballot Notice (As per BSE Announcement Dated on 25/01/2023) Revised outcome of Board meeting dated 25th January, 2023 (As Per BSE Announcement dated on 27.01.2023)

1 2 3

LOGIN HERE

Brooks Laboratories Ltd

Board Meeting